384 related articles for article (PubMed ID: 8462769)
1. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
2. The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.
Ozçelikay AT; Pekiner C; Ari N; Oztürk Y; Ozüari A; Altan VM
Diabetologia; 1994 Jun; 37(6):572-8. PubMed ID: 7926341
[TBL] [Abstract][Full Text] [Related]
3. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
4. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
5. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Ramanadham S; Mongold JJ; Brownsey RW; Cros GH; McNeill JH
Am J Physiol; 1989 Sep; 257(3 Pt 2):H904-11. PubMed ID: 2675634
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
7. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil.
Shafrir E; Spielman S; Nachliel I; Khamaisi M; Bar-On H; Ziv E
Diabetes Metab Res Rev; 2001; 17(1):55-66. PubMed ID: 11241892
[TBL] [Abstract][Full Text] [Related]
8. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
11. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Cam MC; Rodrigues B; McNeill JH
Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
[TBL] [Abstract][Full Text] [Related]
12. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
13. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
14. One-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or haematological indices.
Dai S; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):110-5. PubMed ID: 8190698
[TBL] [Abstract][Full Text] [Related]
15. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.
Mongold JJ; Cros GH; Vian L; Tep A; Ramanadham S; Siou G; Diaz J; McNeill JH; Serrano JJ
Pharmacol Toxicol; 1990 Sep; 67(3):192-8. PubMed ID: 2255674
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
[TBL] [Abstract][Full Text] [Related]
17. Vanadyl sulphate differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo or in vitro exposure.
Cadène A; Gross R; Poucheret P; Mongold JJ; Masiello P; Roye M; Ribes G; Serrano JJ; Cros G
Eur J Pharmacol; 1996 Dec; 318(1):145-51. PubMed ID: 9007526
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic islet beta cell protective effect of oral vanadyl sulphate in streptozotocin-induced diabetic rats, an ultrastructure study.
Ahmadi S; Karimian SM; Sotoudeh M; Bahadori M; Dehghani GA
Pak J Biol Sci; 2010 Dec; 13(23):1135-40. PubMed ID: 21313890
[TBL] [Abstract][Full Text] [Related]
19. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats & evidence for long-term relief of diabetes mellitus.
Dehghani GA; Sotoodeh M; Omrani GR
Indian J Med Res; 1999 Aug; 110():70-5. PubMed ID: 10573657
[TBL] [Abstract][Full Text] [Related]
20. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
Sarangarajan R; Cacini W
Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
